檢索結果 - Sotirios Tsimikas

Refine Results
  1. 1
    Lipoprotein(a)

    Lipoprotein(a) 由 Sotirios Tsimikas

    出版 2016
    獲取全文
    Revisão
    加到收藏夾
    Saved in:
  2. 2
    A Test in Context: Lipoprotein(a)

    A Test in Context: Lipoprotein(a) 由 Sotirios Tsimikas

    出版 2017
    獲取全文
    Revisão
    加到收藏夾
    Saved in:
  3. 3
    Potential Causality and Emerging Medical Therapies for Lipoprotein(a) and Its Associated Oxidized Phospholipids in Calcific Aortic Valve Stenosis

    Potential Causality and Emerging Medical Therapies for Lipoprotein(a) and Its Associated Oxidized Phospholipids in Calcific Aortic Valve Stenosis 由 Sotirios Tsimikas

    出版 2019
    獲取全文 獲取全文
    Revisão
    加到收藏夾
    Saved in:
  4. 4
    Immunomodulatory Effects of Statins

    Immunomodulatory Effects of Statins 由 Wulf Palinski, Sotirios Tsimikas

    出版 2002
    獲取全文
    Revisão
    加到收藏夾
    Saved in:
  5. 5
    Particle Number and Characteristics of Lipoprotein(a), LDL, and apoB

    Particle Number and Characteristics of Lipoprotein(a), LDL, and apoB 由 Sotirios Tsimikas, Vera Bittner

    出版 2024
    獲取全文
    Editorial
    加到收藏夾
    Saved in:
  6. 6
    Lipoprotein(a) as a Potential Causal Genetic Risk Factor of Cardiovascular Disease

    Lipoprotein(a) as a Potential Causal Genetic Risk Factor of Cardiovascular Disease 由 Sotirios Tsimikas, Jennifer L. Hall

    出版 2012
    獲取全文
    Artigo
    加到收藏夾
    Saved in:
  7. 7
    Measuring Circulating Oxidized Low-Density Lipoprotein to Evaluate Coronary Risk

    Measuring Circulating Oxidized Low-Density Lipoprotein to Evaluate Coronary Risk 由 Sotirios Tsimikas, Joseph L. Witztum

    出版 2001
    獲取全文 獲取全文
    Carta
    加到收藏夾
    Saved in:
  8. 8
    Ancestry, Lipoprotein(a), and Cardiovascular Risk Thresholds

    Ancestry, Lipoprotein(a), and Cardiovascular Risk Thresholds 由 Sotirios Tsimikas, Santica M. Marcovina

    出版 2022
    獲取全文
    Revisão
    加到收藏夾
    Saved in:
  9. 9
    The dedicated “Lp(a) clinic”: A concept whose time has arrived?

    The dedicated “Lp(a) clinic”: A concept whose time has arrived? 由 Sotirios Tsimikas, Erik S.G. Stroes

    出版 2020
    獲取全文
    Revisão
    加到收藏夾
    Saved in:
  10. 10
    The Severe Hypercholesterolemia Phenotype

    The Severe Hypercholesterolemia Phenotype 由 Allan D. Sniderman, Sotirios Tsimikas, Sergio Fazio

    出版 2014
    獲取全文
    Revisão
    加到收藏夾
    Saved in:
  11. 11
    The role of oxidized phospholipids in atherosclerosis

    The role of oxidized phospholipids in atherosclerosis 由 Judith A. Berliner, Norbert Leitinger, Sotirios Tsimikas

    出版 2008
    獲取全文
    Artigo
    加到收藏夾
    Saved in:
  12. 12
    C-Reactive Protein and Other Emerging Blood Biomarkers to Optimize Risk Stratification of Vulnerable Patients

    C-Reactive Protein and Other Emerging Blood Biomarkers to Optimize Risk Stratification of Vulnerable Patients 由 Sotirios Tsimikas, James T. Willerson, Paul M. Ridker

    出版 2006
    獲取全文
    Revisão
    加到收藏夾
    Saved in:
  13. 13
    Oxidized Phospholipids on apoB-100-Containing Lipoproteins: a Biomarker Predicting Cardiovascular Disease and Cardiovascular Events

    Oxidized Phospholipids on apoB-100-Containing Lipoproteins: a Biomarker Predicting Cardiovascular Disease and Cardiovascular Events 由 Adam Taleb, Joseph L. Witztum, Sotirios Tsimikas

    出版 2011
    獲取全文
    Revisão
    加到收藏夾
    Saved in:
  14. 14
    Oxidation-specific epitopes and immunological responses: Translational biotheranostic implications for atherosclerosis

    Oxidation-specific epitopes and immunological responses: Translational biotheranostic implications for atherosclerosis 由 Gregor Leibundgut, Joseph L. Witztum, Sotirios Tsimikas

    出版 2013
    獲取全文
    Revisão
    加到收藏夾
    Saved in:
  15. 15
    Lipoprotein(a) and oxidized phospholipids in calcific aortic valve stenosis

    Lipoprotein(a) and oxidized phospholipids in calcific aortic valve stenosis 由 Calvin Yeang, Michael J. Wilkinson, Sotirios Tsimikas

    出版 2016
    獲取全文
    Revisão
    加到收藏夾
    Saved in:
  16. 16
    Novel method for quantification of lipoprotein(a)-cholesterol: implications for improving accuracy of LDL-C measurements

    Novel method for quantification of lipoprotein(a)-cholesterol: implications for improving accuracy of LDL-C measurements 由 Calvin Yeang, Joseph L. Witztum, Sotirios Tsimikas

    出版 2021
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  17. 17
    New Insights Into the Role of Lipoprotein(a)-Associated Lipoprotein-Associated Phospholipase A <sub>2</sub> in Atherosclerosis and Cardiovascular Disease

    New Insights Into the Role of Lipoprotein(a)-Associated Lipoprotein-Associated Phospholipase A <sub>2</sub> in Atherosclerosis and Cardiovascular Disease 由 Sotirios Tsimikas, Loukas D. Tsironis, Alexandros D. Tselepis

    出版 2007
    獲取全文
    Revisão
    加到收藏夾
    Saved in:
  18. 18
    In Vivo Uptake of Radiolabeled MDA2, an Oxidation-Specific Monoclonal Antibody, Provides an Accurate Measure of Atherosclerotic Lesions Rich in Oxidized LDL and Is Highly Sensitive to Their Regression

    In Vivo Uptake of Radiolabeled MDA2, an Oxidation-Specific Monoclonal Antibody, Provides an Accurate Measure of Atherosclerotic Lesions Rich in Oxidized LDL and Is Highly Sensitive... 由 Sotirios Tsimikas, Brian Shortal, Joseph L. Witztum, Wulf Palinski

    出版 2000
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  19. 19
    Prevalence of Elevated Lp(a) Mass Levels and Patient Thresholds in 532 359 Patients in the United States

    Prevalence of Elevated Lp(a) Mass Levels and Patient Thresholds in 532 359 Patients in the United States 由 Stephen A. Varvel, Joseph P. McConnell, Sotirios Tsimikas

    出版 2016
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  20. 20
    Emerging RNA Therapeutics to Lower Blood Levels of Lp(a)

    Emerging RNA Therapeutics to Lower Blood Levels of Lp(a) 由 Sotirios Tsimikas, Patrick M. Moriarty, Erik S.G. Stroes

    出版 2021
    獲取全文
    Revisão
    加到收藏夾
    Saved in:

檢索工具: